Lanning Newell
Gastroenterology · Raleigh, NCNPI 1114926250
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 325 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 30.5% of the total.
Across 325 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Gilead$896
- Pfizer$668
- Takeda Pharmaceuticals U.S.A., Inc.$416
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$402
- Intercept Pharmaceuticals, Inc.$310
- plus $2K from 18 others
What the payments were for
- Food & beverage$6,17697%
- Education$1162%
- Gifts$721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 98 | $1,938 |
| Gilead | 53 | $896 |
| Pfizer | 34 | $668 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $416 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $402 |
| Intercept Pharmaceuticals, Inc. | 9 | $310 |
| Johnson & Johnson(2 entities) | 13 | $280 |
| Redhill Biopharma Inc. | 9 | $265 |
| Bristol Myers Squibb | 13 | $240 |
| Ferring Pharmaceuticals Inc. | 11 | $179 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Amgen | 6 | $107 |
| Braintree Laboratories, Inc. | 6 | $102 |
| Daiichi Sankyo Inc. | 5 | $84 |
| Nestle Healthcare Nutrition Inc. | 4 | $69 |
| Merck | 5 | $65 |
| UCB, Inc. | 3 | $55 |
| Intra-sana Laboratories | 1 | $38 |
| Organon | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Shire North American Group Inc | 1 | $17 |
| QOL Medical, LLC | 1 | $16 |
| Evoke Pharma, Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,364 in reported general payments places this provider in the 75th percentile of 610 gastroenterology providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 19 | $92 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Raleigh
- Rig PatelRaleigh$94K
- Alyson JohnsonRaleigh$52K
- Henry VanpalaRaleigh$40K
- Stephen DealCharlotte$945K
- Fred FowlerCharlotte$932K
- Paul WatkinsChapel Hill$876K
- Nilesh LodhiaCharlotte$735K
- Evan DellonChapel Hill$431K
- Robert ReindollarSalisbury$430K
- Andrew StormWinston Salem$426K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.